Hjem › Plasmacellekreft › Texas
Kliniske studier for Plasmacellekreft i Texas
7 studier for Plasmacellekreft søker deltakere på steder i Texas.
Byer i Texas
Offisiell studietekst (engelsk)
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
- MD Anderson Cancer Center, Houston
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT04879043MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- Baylor University Medical Center, Investigational Drug Services, Department of Pharmacy, Dallas
- Baylor University Medical Center, Dallas
- Houston Methodist Cancer Center Infusion, Houston
- og 9 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT06152575Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma
- M D Anderson Cancer Center, Houston
RekruttererFase 1/2
Alder 18 til 80 · Alle kjønn · Oppdatert 20. aug. 2026 · NCT06066359A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
- University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT05651932A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma
- M D Anderson Cancer Center, Houston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 11. jun. 2026 · NCT05055063Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma
- M D Anderson Cancer Center, Houston
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 15. apr. 2026 · NCT05336383Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
- Mays Cancer Center at UT Health San Antonio, San Antonio
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 20. feb. 2026 · NCT05745285Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.